Role of glucagon in diabetes
- PMID: 403869
Role of glucagon in diabetes
Abstract
The glucagon-secreting A cell is a vital component of the organ system which regulates the distribution of fuel--the islets of Langerhans. Bihormonal control of glucoregulation through a push-pull system maintains the glucose concentration of extracellular fluid within narrow limits irrespective of glucose flux rates through relative equality of glucose influx and efflux. This equality requires appropriate secretion mixtures of the biologic antagonists, insulin and glucagon, directed by a glucose sensor. In severe diabetes, there are virtually no B cells and A cells are in contact largely with other A cells and their glucose-sensing capacity is lost. The A cell hypersecretes and in most juvenile type diabetics aggressive therapy with insulin fails to restore it to normal. Glucagon is a factor in the development of endogenous hyperglycemia, and ketoacidosis. Its suppression may provide a possible approach in the future pharmacologic management of diabetic hyperglycemia.
Similar articles
-
The role of glucagon in diabetes.Compr Ther. 1982 Jan;8(1):53-9. Compr Ther. 1982. PMID: 7039948
-
Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.J Clin Invest. 1976 Aug;58(2):320-5. doi: 10.1172/JCI108475. J Clin Invest. 1976. PMID: 783198 Free PMC article. Clinical Trial.
-
Inhibition of glucagon secretion.Adv Pharmacol. 2005;52:151-71. doi: 10.1016/S1054-3589(05)52008-8. Adv Pharmacol. 2005. PMID: 16492545 Review.
-
Diabetes mellitus secondary to chronic pancreatitis.Dan Med Bull. 1993 Apr;40(2):153-62. Dan Med Bull. 1993. PMID: 8495594 Review.
-
Role of glucagon in the pathogenesis of diabetes: the status of the controversy.Metabolism. 1978 Nov;27(11):1691-709. doi: 10.1016/0026-0495(78)90291-3. Metabolism. 1978. PMID: 360007 Review.
Cited by
-
Different susceptibility of rat pancreatic alpha and beta cells to hypoxia.Histochem Cell Biol. 2012 Jun;137(6):801-10. doi: 10.1007/s00418-012-0925-4. Epub 2012 Feb 5. Histochem Cell Biol. 2012. PMID: 22310982
-
Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.Acta Diabetol Lat. 1980 Apr-Jun;17(2):111-8. doi: 10.1007/BF02580992. Acta Diabetol Lat. 1980. PMID: 7004039
-
Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog.Diabetologia. 1987 Oct;30(10):782-90. doi: 10.1007/BF00275744. Diabetologia. 1987. PMID: 3322904
-
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects.Diabetologia. 2007 Apr;50(4):806-13. doi: 10.1007/s00125-007-0598-z. Epub 2007 Feb 16. Diabetologia. 2007. PMID: 17334652
-
Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.J Biol Chem. 2020 Oct 16;295(42):14379-14390. doi: 10.1074/jbc.REV120.008387. Epub 2020 Aug 12. J Biol Chem. 2020. PMID: 32796035 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources